TWI461426B - (二氫)咪唑並異〔5,1-a〕喹啉類 - Google Patents

(二氫)咪唑並異〔5,1-a〕喹啉類 Download PDF

Info

Publication number
TWI461426B
TWI461426B TW099114528A TW99114528A TWI461426B TW I461426 B TWI461426 B TW I461426B TW 099114528 A TW099114528 A TW 099114528A TW 99114528 A TW99114528 A TW 99114528A TW I461426 B TWI461426 B TW I461426B
Authority
TW
Taiwan
Prior art keywords
alkyl
group
vacuo
concentrated
methoxy
Prior art date
Application number
TW099114528A
Other languages
English (en)
Chinese (zh)
Other versions
TW201107322A (en
Inventor
Hubert Jan Jozef Loozen
Cornelis Marius Timmers
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Publication of TW201107322A publication Critical patent/TW201107322A/zh
Application granted granted Critical
Publication of TWI461426B publication Critical patent/TWI461426B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pregnancy & Childbirth (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
TW099114528A 2009-05-27 2010-05-06 (二氫)咪唑並異〔5,1-a〕喹啉類 TWI461426B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09161274 2009-05-27

Publications (2)

Publication Number Publication Date
TW201107322A TW201107322A (en) 2011-03-01
TWI461426B true TWI461426B (zh) 2014-11-21

Family

ID=42315817

Family Applications (1)

Application Number Title Priority Date Filing Date
TW099114528A TWI461426B (zh) 2009-05-27 2010-05-06 (二氫)咪唑並異〔5,1-a〕喹啉類

Country Status (8)

Country Link
EP (1) EP2435433B1 (enExample)
JP (1) JP5647675B2 (enExample)
CN (1) CN102448961B (enExample)
AR (1) AR076703A1 (enExample)
AU (1) AU2010252007B2 (enExample)
CA (1) CA2763118A1 (enExample)
TW (1) TWI461426B (enExample)
WO (1) WO2010136438A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6170043B2 (ja) 2011-07-01 2017-07-26 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung ジヒドロピラゾール
WO2013012848A1 (en) 2011-07-18 2013-01-24 Merck Patent Gmbh Benzamides
ES2663972T3 (es) 2012-01-10 2018-04-17 Merck Patent Gmbh Derivados de benzamida como moduladores de la hormona folículo estimulante
KR20140120903A (ko) 2012-02-08 2014-10-14 메르크 파텐트 게엠베하 여포 자극 호르몬수용체의 아고니스트로서 중수소화 티아졸리디논 유사체
EP3013823B1 (en) 2013-06-24 2017-11-01 Merck Patent GmbH Imidazole compounds as modulators of fshr and uses thereof
RU2663898C2 (ru) 2013-06-24 2018-08-13 Мерк Патент Гмбх Пиразольные соединения в качестве модуляторов fshr и их применение
WO2015123424A1 (en) 2014-02-13 2015-08-20 Incyte Corporation Cyclopropylamines as lsd1 inhibitors
US9527835B2 (en) 2014-02-13 2016-12-27 Incyte Corporation Cyclopropylamines as LSD1 inhibitors
EP3392244A1 (en) 2014-02-13 2018-10-24 Incyte Corporation Cyclopropylamines as lsd1 inhibitors
LT3105218T (lt) 2014-02-13 2019-12-10 Incyte Corp Ciklopropilaminai kaip lsd1 inhibitoriai
WO2015196335A1 (en) * 2014-06-23 2015-12-30 Tocopherx, Inc. Pyrazole compounds as modulators of fshr and uses thereof
WO2016007731A1 (en) 2014-07-10 2016-01-14 Incyte Corporation Imidazopyridines and imidazopyrazines as lsd1 inhibitors
WO2016007722A1 (en) 2014-07-10 2016-01-14 Incyte Corporation Triazolopyridines and triazolopyrazines as lsd1 inhibitors
US9758523B2 (en) 2014-07-10 2017-09-12 Incyte Corporation Triazolopyridines and triazolopyrazines as LSD1 inhibitors
WO2016007736A1 (en) 2014-07-10 2016-01-14 Incyte Corporation Imidazopyrazines as lsd1 inhibitors
EA201792205A1 (ru) 2015-04-03 2018-02-28 Инсайт Корпорейшн Гетероциклические соединения как ингибиторы lsd1
DK3334709T3 (da) 2015-08-12 2025-02-03 Incyte Holdings Corp Salte af en lsd1-hæmmer
CA3021678A1 (en) 2016-04-22 2017-10-26 Incyte Corporation Formulations of an lsd1 inhibitor
CN106866692A (zh) * 2017-03-30 2017-06-20 毛阿龙 具有苯并1,4‑二氧杂环己二烯酮结构的fshr拮抗剂的制备方法
US10968200B2 (en) 2018-08-31 2021-04-06 Incyte Corporation Salts of an LSD1 inhibitor and processes for preparing the same
WO2024077006A1 (en) * 2022-10-05 2024-04-11 Radionetics Oncology, Inc. Follicle-stimulating hormone receptor (fshr) targeted therapeutics and uses thereof
WO2024184461A2 (en) 2023-03-08 2024-09-12 Ferring B.V. Small molecule fsh receptor modulators

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000008015A2 (en) * 1998-08-07 2000-02-17 Applied Research Systems Ars Holding N.V. Fsh mimetics for the treatment of infertility
WO2003004028A1 (en) * 2001-07-02 2003-01-16 Akzo Nobel N.V. Tetrahydroquinoline derivatives
US20040259792A1 (en) * 2003-04-01 2004-12-23 Palmer Stephen S. Inhibitors of phosphodiesterases in infertility

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO66801A (fr) * 1973-05-25 1979-08-15 Lepetit Spa Procede pour obtenir des derives des triazoloizoquinolines
PH15001A (en) * 1977-07-25 1982-03-22 Sandoz Ag Prolactin secretion inhibitors
MXPA05013553A (es) * 2003-06-30 2006-03-09 Altana Pharma Ag Pirrolodihidroisoquinolinas como inhibidores de pde10.
TW200944523A (en) * 2008-02-08 2009-11-01 Organon Nv (Dihydro)pyrrolo[2,1-a]isoquinolines

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000008015A2 (en) * 1998-08-07 2000-02-17 Applied Research Systems Ars Holding N.V. Fsh mimetics for the treatment of infertility
WO2003004028A1 (en) * 2001-07-02 2003-01-16 Akzo Nobel N.V. Tetrahydroquinoline derivatives
US20040259792A1 (en) * 2003-04-01 2004-12-23 Palmer Stephen S. Inhibitors of phosphodiesterases in infertility

Also Published As

Publication number Publication date
WO2010136438A1 (en) 2010-12-02
AU2010252007B2 (en) 2014-06-05
AU2010252007A1 (en) 2011-12-22
EP2435433A1 (en) 2012-04-04
JP5647675B2 (ja) 2015-01-07
EP2435433B1 (en) 2013-08-28
CN102448961A (zh) 2012-05-09
CN102448961B (zh) 2016-01-06
CA2763118A1 (en) 2010-12-02
AR076703A1 (es) 2011-06-29
JP2012528105A (ja) 2012-11-12
TW201107322A (en) 2011-03-01

Similar Documents

Publication Publication Date Title
EP2435433B1 (en) (dihydro)imidazoiso[5,1-a]quinolines as fsh receptor agonists for the treatment of fertility disorders
KR102384668B1 (ko) Apj 효능제로서의 6-히드록시-5-(페닐/헤테로아릴술포닐)피리미딘-4(1h)-온
CN105189508B (zh) 作为janus激酶抑制剂的环烷基腈吡唑并吡啶酮
JP5620823B2 (ja) (ジヒドロ)ピロロ[2,1−a]イソキノリン
CN105120862A (zh) Wnt信号途径的3-(苯并咪唑-2-基)-吲唑抑制剂及其治疗应用
CN101490014A (zh) 苯并咪唑和氮杂苯并咪唑的区域选择性钯催化合成
TW201725203A (zh) 作為apj受體促效劑之雜芳基羥基嘧啶酮
CN110072850A (zh) 3-磺酰基-5-氨基吡啶-2,4-二醇apj激动剂
EP2079738A2 (en) 7-azaindole derivatives as c-met kinase inhibitors
JP2013541592A (ja) ヘキサヒドロインデノピリジン及びオクタヒドロベンゾキノリンのアリール−及びヘテロアリールカルボニル誘導体
CN119176808B (zh) 一种glp-1激动剂及其制备方法和应用
KR20200083529A (ko) 파르네소이드 x 수용체 조정제로서의 알켄 스피로시클릭 화합물
KR20090074179A (ko) Ppar 조절제로서 유용한 1h­인돌­2­카르복실산 유도체
IL186831A (en) History 4 - Phenyl - 5 - Oxo - 8,7,6,5,4,1 - Hexahydroquinoline as a drug for the treatment of infertility
US8431564B2 (en) Ring-annulated dihydropyrrolo[2,1-α]isoquinolines
CA2849111C (en) Fsh receptor antagonists
RU2530775C2 (ru) ПРОИЗВОДНЫЕ 1Н-ПИРАЗОЛО[4,3-c]ИЗОХИНОЛИНОВ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЕ В ТЕРАПИИ
US8071587B2 (en) (Dihydro)imidazoiso[5,1-A]quinolines
EP2459551B1 (en) Dihydrobenzoindazoles
US8071589B2 (en) Dihydrobenzoindazoles
TW201116531A (en) Ring-annulated dihydropyrrolo[2,1-a]isoquinolines
TW200524902A (en) 2-substituted benzimidazole piperidines analogs as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
MXPA05006588A (es) Compuestos de pirazol como derivados antagonistas del receptor de la integrina.
HK1124044A (en) 6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees